SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 3 filers reported holding SEATTLE GENETICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,455,000 | -15.8% | 12,734 | -37.1% | 0.06% | +10.2% |
| Q3 2019 | $1,728,000 | +35.2% | 20,233 | +16.0% | 0.06% | +11.3% |
| Q1 2019 | $1,278,000 | -4.6% | 17,443 | -26.2% | 0.05% | +103.8% |
| Q4 2018 | $1,339,000 | -32.3% | 23,638 | -7.9% | 0.03% | -48.0% |
| Q3 2018 | $1,979,000 | +76.7% | 25,655 | +52.1% | 0.05% | +28.2% |
| Q2 2018 | $1,120,000 | -28.5% | 16,866 | -43.7% | 0.04% | -23.5% |
| Q1 2018 | $1,567,000 | +25.5% | 29,932 | +28.2% | 0.05% | +59.4% |
| Q4 2017 | $1,249,000 | -2.4% | 23,346 | -5.6% | 0.03% | -17.9% |
| Q2 2017 | $1,280,000 | +329.5% | 24,739 | +422.7% | 0.04% | +333.3% |
| Q1 2017 | $298,000 | -36.7% | 4,733 | -45.8% | 0.01% | -18.2% |
| Q3 2016 | $471,000 | -44.9% | 8,729 | -60.6% | 0.01% | -62.1% |
| Q3 2015 | $855,000 | – | 22,173 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |